Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
2024年3月6日 - 10:00PM
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical
company focused on the development and commercialization of
therapeutics for central nervous system (CNS) disorders, today
announced that it will participate in three upcoming investor
conferences:
Leerink Partners Global Biopharma
ConferenceTuesday, March 12, 2024 at 10:40 a.m. ET in
Miami, FL
Jefferies Biotech on the Bay Summit Wednesday,
March 13, 2024 in Miami, FL
UBS Virtual CNS DayMonday, March 18, 2024
A live and achieved webcast of the Company’s presentation
at the Leerink Partners Global Biopharma Conference can be accessed
under "Events & Presentations" in the Investor Relations
section of the Company's website at www.intracellulartherapies.com.
Please log in approximately 5-10 minutes prior to the event to
register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded
on Nobel prize-winning research that allows us to understand how
therapies affect the inner-workings of cells in the body. The
company leverages this intracellular approach to develop innovative
treatments for people living with complex psychiatric and
neurologic diseases. For more information, please visit
www.intracellulartherapies.com.
Contact:
Intra-Cellular Therapies, Inc.Juan Sanchez, M.D. Vice President,
Corporate Communications and Investor Relations646-440-9333
Burns McClellan, Inc.Cameron
Radinoviccradinovic@burnsmc.com212-213-0006
Intra Cellular Therapies (NASDAQ:ITCI)
過去 株価チャート
から 4 2024 まで 5 2024
Intra Cellular Therapies (NASDAQ:ITCI)
過去 株価チャート
から 5 2023 まで 5 2024